Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study.
Fiche publication
Date publication
mai 2020
Journal
Journal of clinical medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ORNETTI Paul
Tous les auteurs :
Pascart T, Ramon A, Ottaviani S, Legrand J, Ducoulombier V, Houvenagel E, Norberciak L, Richette P, Becce F, Ornetti P, Budzik JF
Lien Pubmed
Résumé
(1) Background: To determine which factors are associated with the volume of monosodium urate (MSU) crystal deposition quantified by dual-energy computed tomography (DECT) in urate-lowering therapy (ULT)-naive gout patients. (2) Methods: In this multicenter cross-sectional study, DECT scans of knees and feet/ankles were prospectively obtained from ULT-naive gout patients. Demographic, clinical (including gout history and comorbidities), and biological data were collected, and their association with DECT MSU crystal volume was analyzed using bivariate and multivariate analyses. A second bivariate analysis was performed by splitting the dataset depending on an arbitrary threshold of DECT MSU volume (1 cm). (3) Results: A total of 91 patients were included. In the bivariate analysis, age ( = 0.03), gout duration ( = 0.003), subcutaneous tophi ( = 0.004), hypertension ( = 0.02), diabetes mellitus ( = 0.05), and chronic heart failure ( = 0.03) were associated with the total DECT volume of MSU crystal deposition. In the multivariate analysis, factors associated with DECT MSU volumes ≥1 cm were gout duration (odds ratio (OR) for each 10-year increase 3.15 (1.60; 7.63)), diabetes mellitus (OR 4.75 (1.58; 15.63)), and chronic heart failure (OR 7.82 (2.29; 31.38)). (4) Conclusion: Specific comorbidities, particularly chronic heart failure and diabetes mellitus, are more strongly associated with increased MSU crystal deposition in knees and feet/ankles than gout duration, regardless of serum urate level.
Mots clés
chronic heart failure, comorbidities, diabetes mellitus, dual-energy computed tomography, gout, monosodium urate crystal deposition
Référence
J Clin Med. 2020 May 1;9(5):